30 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
7 Nov 23
Maravai Lifesciences Reports Third Quarter 2023 Financial Results
4:11pm
for mRNA Medicines (AMM). With the founding of the Alliance for mRNA Medicines, our community is now poised to champion scientific standards and public
8-K
EX-99.1
l9d3g1cpz6 1qqg8e1
10 Nov 21
Maravai Lifesciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance for 2022
4:09pm
424B4
yk3y v5c2w3jtio
13 Sep 21
Prospectus supplement with pricing info
4:16pm
DRS
7bf7w42 fwbe883
26 Aug 21
Draft registration statement
12:00am
DEF 14A
bc0a5vbz3j9rjcogbbnc
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
8mf6fw8fgvnkf3ytbgu2
9 Apr 21
Preliminary proxy
4:16pm
424B4
jrdnbc8qc r4l
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
jxaapz57
25 Mar 21
Draft registration statement
12:00am
10-K
cjwhyc9 pm3rjnvsoi8
22 Mar 21
Annual report
4:22pm
8-K
EX-10.1
ek9qn17b99 jydy9uyy
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
S-8
EX-10.2
nmop7ebgpik7xhgigs49
23 Nov 20
Registration of securities for employees
5:06pm
424B4
3qqjgrwd1antg
23 Nov 20
Prospectus supplement with pricing info
4:36pm